- €25.34m
- €29.64m
- €27.80m
- 67
- 50
- 74
- 72
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | — | — | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 19.1 | 21 | 21.8 | 24.9 | 27.8 |
Cost of Revenue | |||||
Gross Profit | 15.8 | 17.4 | 18.3 | 20.4 | 21.9 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 17.8 | 19.9 | 20.4 | 23.1 | 26.1 |
Operating Profit | 1.31 | 1.14 | 1.41 | 1.78 | 1.66 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 1.2 | 0.933 | 1.25 | 1.61 | 1.49 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.75 | 0.572 | 0.903 | 1.08 | 0.981 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.75 | 0.572 | 0.903 | 1.08 | 0.981 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.75 | 0.572 | 0.903 | 1.08 | 0.981 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.061 | 0.046 | 0.072 | 0.086 | 0.083 |
Dividends per Share |